Esperion Therapeutics Inc (ESPR)
2.16
-0.13
(-5.68%)
USD |
NASDAQ |
May 31, 16:00
2.21
+0.05
(+2.31%)
After-Hours: 07:44
Esperion Therapeutics Debt to Equity Ratio: -0.8904 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | -0.8904 |
December 31, 2023 | -0.5749 |
September 30, 2023 | -0.637 |
June 30, 2023 | -0.701 |
March 31, 2023 | -0.7896 |
December 31, 2022 | -0.8027 |
September 30, 2022 | -0.8823 |
June 30, 2022 | -0.8882 |
March 31, 2022 | -1.039 |
December 31, 2021 | -1.311 |
September 30, 2021 | -0.7513 |
Date | Value |
---|---|
June 30, 2021 | -0.8941 |
March 31, 2021 | -1.008 |
December 31, 2020 | -1.866 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.866
Minimum
Dec 2020
--
Maximum
Jun 2019
-0.6518
Average
-0.7704
Median
Debt to Equity Ratio Benchmarks
Dynavax Technologies Corp | 0.3605 |
Masimo Corp | 0.6417 |
United Therapeutics Corp | 0.1124 |
Deciphera Pharmaceuticals Inc | 0.00 |
Ligand Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 373.06M |
Total Liabilities (Quarterly) | 667.36M |
Shareholders Equity (Quarterly) | -294.30M |
Current Ratio | 2.222 |
Net Debt Paydown Yield | -0.08% |